Innovita Biological Technology Co. Ltd. A (688253) - Total Liabilities

Latest as of March 2026: CN¥136.00 Million CNY ≈ $19.90 Million USD

Based on the latest financial reports, Innovita Biological Technology Co. Ltd. A (688253) has total liabilities worth CN¥136.00 Million CNY (≈ $19.90 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Innovita Biological Technology Co. Ltd. (688253) net asset momentum to track the company's year-over-year net asset growth rate.

Innovita Biological Technology Co. Ltd. A - Total Liabilities Trend (2020–2025)

This chart illustrates how Innovita Biological Technology Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. See Innovita Biological Technology Co. Ltd. (688253) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Innovita Biological Technology Co. Ltd. A Competitors by Total Liabilities

The table below lists competitors of Innovita Biological Technology Co. Ltd. A ranked by their total liabilities.

Company	Country	Total Liabilities
C*Core Technology Co Ltd SHG:688262	China	CN¥1.23 Billion
Zhejiang Jiahua Energy Chemical Industry Co Ltd SHG:600273	China	CN¥3.66 Billion
PNC Process Systems Co Ltd SHG:603690	China	CN¥9.60 Billion
Zhejiang Jingu Co Ltd SHE:002488	China	CN¥5.18 Billion
Xpel Inc NASDAQ:XPEL	USA	$113.84 Million
Red Cat Holdings Inc NASDAQ:RCAT	USA	$43.15 Million
Wacker Neuson SE F:WAC	Germany	€989.80 Million
Perpetual Limited F:PVQ	Germany	€1.77 Billion

Liability Composition Analysis (2020–2025)

This chart breaks down Innovita Biological Technology Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Innovita Biological Technology Co. Ltd. (688253) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	15.58	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.06	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.06	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Innovita Biological Technology Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Innovita Biological Technology Co. Ltd. A (2020–2025)

The table below shows the annual total liabilities of Innovita Biological Technology Co. Ltd. A from 2020 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥223.32 Million ≈ $32.68 Million	+1.94%
2024-12-31	CN¥219.07 Million ≈ $32.06 Million	-2.05%
2023-12-31	CN¥223.65 Million ≈ $32.73 Million	-11.69%
2022-12-31	CN¥253.24 Million ≈ $37.06 Million	+324.16%
2021-12-31	CN¥59.70 Million ≈ $8.74 Million	-47.67%
2020-12-31	CN¥114.08 Million ≈ $16.69 Million	--

About Innovita Biological Technology Co. Ltd. A

SHG:688253 China Biotechnology

Market Cap

$1.32 Billion

CN¥9.02 Billion CNY

Market Cap Rank

#7717 Global

#1730 in China

Share Price

CN¥65.88

Change (1 day)

+9.15%

52-Week Range

CN¥30.08 - CN¥65.91

All Time High

CN¥65.91